Calcium and vitamin D supplementation and cognitive impairment in the Women's health initiative

Rebecca C. Rossom, Mark A. Espeland, Joann E. Manson, Maurice W. Dysken, Karen Johnson, Dorothy S. Lane, Erin S. Leblanc, Frank A. Lederle, Kamal H. Masaki, Karen L. Margolis

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Objectives To examine the effects of vitamin D and calcium on cognitive outcomes in elderly women. Design Post hoc analysis of a randomized double-blind placebo-controlled trial. Setting Forty Women's Health Initiative (WHI) clinical centers across the United States. Participants Four thousand one hundred forty-three women aged 65 and older without probable dementia at baseline who participated in the WHI Calcium and Vitamin D Trial and the WHI Memory Study. Intervention Two thousand thirty-four women were randomized to receive 1,000 mg of calcium carbonate combined with 400 IU of vitamin D 3 (treatment) and 2,109 to placebo. Measurements Primary: classifications of probable dementia or mild cognitive impairment (MCI) based on a four-phase protocol that included central adjudication. Secondary: global cognitive function and individual cognitive subtests. Results Mean age of participants was 71. During a mean follow-up of 7.8 years, 39 participants in the treatment group and 37 in the placebo group developed incident dementia (hazard ratio (HR) = 1.11, 95% confidence interval (CI) = 0.71-1.74, P = .64). Likewise, 98 treatment participants and 108 placebo participants developed incident MCI (HR = 0.95, 95% CI = 0.72-1.25, P = .72). There were no significant differences in incident dementia or MCI or in global or domain-specific cognitive function between groups. Conclusion There was no association between treatment assignment and incident cognitive impairment. Further studies are needed to investigate the effects of vitamin D and calcium separately, on men, in other age and ethnic groups, and with other doses.

Original languageEnglish (US)
Pages (from-to)2197-2205
Number of pages9
JournalJournal of the American Geriatrics Society
Volume60
Issue number12
DOIs
StatePublished - Dec 1 2012

Fingerprint

Women's Health
Vitamin D
Dementia
Placebos
Calcium
Cognition
Confidence Intervals
Ergocalciferols
Calcium Carbonate
Cholecalciferol
Therapeutics
Ethnic Groups
Age Groups
Cognitive Dysfunction

All Science Journal Classification (ASJC) codes

  • Geriatrics and Gerontology

Cite this

Rossom, R. C., Espeland, M. A., Manson, J. E., Dysken, M. W., Johnson, K., Lane, D. S., ... Margolis, K. L. (2012). Calcium and vitamin D supplementation and cognitive impairment in the Women's health initiative. Journal of the American Geriatrics Society, 60(12), 2197-2205. https://doi.org/10.1111/jgs.12032

Calcium and vitamin D supplementation and cognitive impairment in the Women's health initiative. / Rossom, Rebecca C.; Espeland, Mark A.; Manson, Joann E.; Dysken, Maurice W.; Johnson, Karen; Lane, Dorothy S.; Leblanc, Erin S.; Lederle, Frank A.; Masaki, Kamal H.; Margolis, Karen L.

In: Journal of the American Geriatrics Society, Vol. 60, No. 12, 01.12.2012, p. 2197-2205.

Research output: Contribution to journalArticle

Rossom, RC, Espeland, MA, Manson, JE, Dysken, MW, Johnson, K, Lane, DS, Leblanc, ES, Lederle, FA, Masaki, KH & Margolis, KL 2012, 'Calcium and vitamin D supplementation and cognitive impairment in the Women's health initiative', Journal of the American Geriatrics Society, vol. 60, no. 12, pp. 2197-2205. https://doi.org/10.1111/jgs.12032
Rossom, Rebecca C. ; Espeland, Mark A. ; Manson, Joann E. ; Dysken, Maurice W. ; Johnson, Karen ; Lane, Dorothy S. ; Leblanc, Erin S. ; Lederle, Frank A. ; Masaki, Kamal H. ; Margolis, Karen L. / Calcium and vitamin D supplementation and cognitive impairment in the Women's health initiative. In: Journal of the American Geriatrics Society. 2012 ; Vol. 60, No. 12. pp. 2197-2205.
@article{6f66dbddb8684043b615697efc4a8080,
title = "Calcium and vitamin D supplementation and cognitive impairment in the Women's health initiative",
abstract = "Objectives To examine the effects of vitamin D and calcium on cognitive outcomes in elderly women. Design Post hoc analysis of a randomized double-blind placebo-controlled trial. Setting Forty Women's Health Initiative (WHI) clinical centers across the United States. Participants Four thousand one hundred forty-three women aged 65 and older without probable dementia at baseline who participated in the WHI Calcium and Vitamin D Trial and the WHI Memory Study. Intervention Two thousand thirty-four women were randomized to receive 1,000 mg of calcium carbonate combined with 400 IU of vitamin D 3 (treatment) and 2,109 to placebo. Measurements Primary: classifications of probable dementia or mild cognitive impairment (MCI) based on a four-phase protocol that included central adjudication. Secondary: global cognitive function and individual cognitive subtests. Results Mean age of participants was 71. During a mean follow-up of 7.8 years, 39 participants in the treatment group and 37 in the placebo group developed incident dementia (hazard ratio (HR) = 1.11, 95{\%} confidence interval (CI) = 0.71-1.74, P = .64). Likewise, 98 treatment participants and 108 placebo participants developed incident MCI (HR = 0.95, 95{\%} CI = 0.72-1.25, P = .72). There were no significant differences in incident dementia or MCI or in global or domain-specific cognitive function between groups. Conclusion There was no association between treatment assignment and incident cognitive impairment. Further studies are needed to investigate the effects of vitamin D and calcium separately, on men, in other age and ethnic groups, and with other doses.",
author = "Rossom, {Rebecca C.} and Espeland, {Mark A.} and Manson, {Joann E.} and Dysken, {Maurice W.} and Karen Johnson and Lane, {Dorothy S.} and Leblanc, {Erin S.} and Lederle, {Frank A.} and Masaki, {Kamal H.} and Margolis, {Karen L.}",
year = "2012",
month = "12",
day = "1",
doi = "10.1111/jgs.12032",
language = "English (US)",
volume = "60",
pages = "2197--2205",
journal = "Journal of the American Geriatrics Society",
issn = "0002-8614",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Calcium and vitamin D supplementation and cognitive impairment in the Women's health initiative

AU - Rossom, Rebecca C.

AU - Espeland, Mark A.

AU - Manson, Joann E.

AU - Dysken, Maurice W.

AU - Johnson, Karen

AU - Lane, Dorothy S.

AU - Leblanc, Erin S.

AU - Lederle, Frank A.

AU - Masaki, Kamal H.

AU - Margolis, Karen L.

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Objectives To examine the effects of vitamin D and calcium on cognitive outcomes in elderly women. Design Post hoc analysis of a randomized double-blind placebo-controlled trial. Setting Forty Women's Health Initiative (WHI) clinical centers across the United States. Participants Four thousand one hundred forty-three women aged 65 and older without probable dementia at baseline who participated in the WHI Calcium and Vitamin D Trial and the WHI Memory Study. Intervention Two thousand thirty-four women were randomized to receive 1,000 mg of calcium carbonate combined with 400 IU of vitamin D 3 (treatment) and 2,109 to placebo. Measurements Primary: classifications of probable dementia or mild cognitive impairment (MCI) based on a four-phase protocol that included central adjudication. Secondary: global cognitive function and individual cognitive subtests. Results Mean age of participants was 71. During a mean follow-up of 7.8 years, 39 participants in the treatment group and 37 in the placebo group developed incident dementia (hazard ratio (HR) = 1.11, 95% confidence interval (CI) = 0.71-1.74, P = .64). Likewise, 98 treatment participants and 108 placebo participants developed incident MCI (HR = 0.95, 95% CI = 0.72-1.25, P = .72). There were no significant differences in incident dementia or MCI or in global or domain-specific cognitive function between groups. Conclusion There was no association between treatment assignment and incident cognitive impairment. Further studies are needed to investigate the effects of vitamin D and calcium separately, on men, in other age and ethnic groups, and with other doses.

AB - Objectives To examine the effects of vitamin D and calcium on cognitive outcomes in elderly women. Design Post hoc analysis of a randomized double-blind placebo-controlled trial. Setting Forty Women's Health Initiative (WHI) clinical centers across the United States. Participants Four thousand one hundred forty-three women aged 65 and older without probable dementia at baseline who participated in the WHI Calcium and Vitamin D Trial and the WHI Memory Study. Intervention Two thousand thirty-four women were randomized to receive 1,000 mg of calcium carbonate combined with 400 IU of vitamin D 3 (treatment) and 2,109 to placebo. Measurements Primary: classifications of probable dementia or mild cognitive impairment (MCI) based on a four-phase protocol that included central adjudication. Secondary: global cognitive function and individual cognitive subtests. Results Mean age of participants was 71. During a mean follow-up of 7.8 years, 39 participants in the treatment group and 37 in the placebo group developed incident dementia (hazard ratio (HR) = 1.11, 95% confidence interval (CI) = 0.71-1.74, P = .64). Likewise, 98 treatment participants and 108 placebo participants developed incident MCI (HR = 0.95, 95% CI = 0.72-1.25, P = .72). There were no significant differences in incident dementia or MCI or in global or domain-specific cognitive function between groups. Conclusion There was no association between treatment assignment and incident cognitive impairment. Further studies are needed to investigate the effects of vitamin D and calcium separately, on men, in other age and ethnic groups, and with other doses.

UR - http://www.scopus.com/inward/record.url?scp=84870999536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870999536&partnerID=8YFLogxK

U2 - 10.1111/jgs.12032

DO - 10.1111/jgs.12032

M3 - Article

VL - 60

SP - 2197

EP - 2205

JO - Journal of the American Geriatrics Society

JF - Journal of the American Geriatrics Society

SN - 0002-8614

IS - 12

ER -